Mark T. Bertolini, Chief Executive Officer of Oscar Health, Inc. (OSCR), acquired 1,000,000 shares of the company's stock on April 7, 2026, for approximately $11.92 million. The purchase was executed at an average price of $11.92 per share.
This significant acquisition by a key executive is often viewed as a signal of strong confidence in the company's future performance and strategic direction.
The transaction occurred amidst recent insider selling activity, including sales by Janet Liang, Victoria Baltrus, Adam McAnaney, and Mario Schlosser in early March, which totaled over $700,000.